Výsledky vyhledávání - Huang, Funan
- Zobrazuji výsledky 1 - 5 z 5
-
1
No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects Autor Huang, Funan, Ajavon, Antoinette, Huang, Erya, Lettieri, John, Liu, Rong, Peña, Carol, Berse, Matthias
Vydáno 2017Text -
2
Clinical Pharmacokinetics of the Androgen Receptor Inhibitor Darolutamide in Healthy Subjects and Patients with Hepatic or Renal Impairment Autor Zurth, Christian, Nykänen, Pirjo, Wilkinson, Gary, Taavitsainen, Päivi, Vuorela, Annamari, Huang, Funan, Reschke, Susanne, Koskinen, Mikko
Vydáno 2021Text -
3
A phase 1b study evaluating the safety and pharmacokinetics of regorafenib in combination with cetuximab in patients with advanced solid tumors Autor Weekes, Colin, Lockhart, A. Craig, Lee, James J., Sturm, Isrid, Cleton, Adriaan, Huang, Funan, Lenz, Heinz‐Josef
Vydáno 2019Text -
4
Exposure–Response Modeling and Simulation of Progression‐Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid Cancer Autor Grevel, Joachim, Jentsch, Garrit, Austin, Rupert, Prins, Nicolaas H., Lettieri, John, Mitchell, David, Huang, Funan, Brose, Marcia S., Schlumberger, Martin, Meinhardt, Gerold, Peña, Carol E. A., Ploeger, Bart A.
Vydáno 2019Text -
5
Prolonged Response to Regorafenib in a Patient with Iodine Refractory Thyroid Cancer Autor Wong, Selina K., Chu, Quincy S.C., Spratlin, Jennifer L., Sangha, Randeep, McEwan, Alexander J.B., Morrish, Donald W., Arndt, Diane, Sergenson, Gwen, Cleton, Adriaan, Huang, Funan, Sawyer, Michael B.
Vydáno 2019Text